Navigation Links
Novation Announces the Addition of St. Jude Medical to the Cardiac Rhythm Management Products Portfolio
Date:4/8/2011

IRVING, Texas, April 8, 2011 /PRNewswire/ -- Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.

St. Jude Medical is a leading provider of medical devices which treat cardiac, neurological and chronic pain patients. The company provides a full portfolio of arrhythmia management products, including pacemakers, implantable cardioverter defibrillators (ICDs) and leads.

Effective April 1, 2011 the agreement features a complete product offering, locally-negotiated pricing and market share growth rebates as well as price protections and transparency offered through GPO contracts. The new 30-month agreement marks the first collaboration between Novation and St. Jude Medical.

"We are pleased to partner with Novation and their member hospitals to provide additional access to St. Jude Medical's life sustaining technologies. The new agreement has the potential to both increase the use of our arrhythmia management therapies and help to create efficiencies in the supply chain," said Mike Rousseau, Group President of St. Jude Medical.

During Novation's due diligence in this product category, the members of VHA Inc., the University HealthSystem Consortium (UHC) and Provista were overwhelmingly supportive of St. Jude Medical and their products. The products were viewed as both innovative and relevant to meeting their needs of providing quality care at an appropriate price.

"We are excited about the new agreement with St. Jude Medical and how it rounds out our already strong portfolio in this space. We view their products as being both innovative and relevant to meeting the needs of our members," said Pete Allen, senior vice president, sourcing operations at Novation. "We are looking forward to St. Jude Medical's pipeline of new technologies, many which we expect to soon be available in the United Stat
'/>"/>

SOURCE Novation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Quest Diagnostics Honored for Diagnostic Innovation at 2011 Edison Awards
2. Freedom Innovations Opens New European Headquarters
3. Awarepoint CEO Jay Deady to Serve as Panelist at IBFs Digital Healthcare Innovation Summit
4. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
5. Lilly CEO Calls for Biopharmaceutical Industry Changes and Policies That Encourage Medical Innovation
6. Echo Therapeutics Receives Frost & Sullivans 2011 Technology Innovation Award
7. NorTech, Crains Cleveland Business Announce 2011 Innovation Award Winners
8. Medtronic Inc. Cancels Cardiovascular and Orthopedic Contracts With Novation
9. Enox Biopharma, Inc. to Present at IN3 West Investment in Innovation Conference.
10. CVS Caremark Awarded Pharmacy Benefit Management Institute Rx Benefit Innovation Award for Pharmacy Advisor Program
11. Reportlinker Adds Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... NEW YORK , May 22, 2013 ... Gross LLP is investigating claims on behalf of investors ... (NASDAQ: ISRG ) (CUSIP: 46120E602) who purchased ... April 18, 2013 (the "Class Period"). Such investors are ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ...
(Date:5/22/2013)... Z-Medica, a leading developer and marketer of ... line of products designed to meet the unique needs ... EMS 4x4 Dressing, QuikClot ® EMS TraumaPad ... all custom-designed to help responders stop bleeding fast and ... a hospital or trauma center. The line includes products ...
(Date:5/22/2013)... , May 22, 2013 STEPh, Inc., ... announce the launch of their web site ( ... Reports].  About STEPh Reports ... development.  Each STEPh Report assesses the ... data, projected launch year, company, and specific key issues.  ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2
... TOKYO and CHIPPENHAM, England, October 7 ,Sosei ... and Vectura,Group plc ("Vectura"; LSE: VEC), announce ... efficacy, safety and tolerability of NVA237 presented ... Society (ERS) in Berlin,Germany. The new data ...
... of Gastroenterology Annual ... ... two Phase 3,studies presented at the American College of Gastroenterology Annual,Scientific ... rates than lansoprazole among patients with more,severe grades of erosive esophagitis ...
Cached Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 2Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 3
(Date:5/22/2013)... Rochester, NY (PRWEB) May 22, 2013 ... can now have access to Adapt Courseware’s new ... curriculum in an adaptive framework that responds based ... Adapt Courseware , the provider of comprehensive adaptive ... experience, is continuing to develop introductory level general ...
(Date:5/22/2013)... Jersey (PRWEB) May 22, 2013 Ethos ... gift card system, fit for the busy lifestyle of the ... select a design appropriate for the occasion, whether it is ... an apology note, or any other occasion. , Clients should ... Jersey spa gift card designs on the Ethos Spa’s ...
(Date:5/22/2013)... TheBeautyPlace.com features Toppik and Bosley hair fibers, two ... of thinning or balding hair. Hair loss treatments can be ... hair loss during this waiting period, one can use these ... alternative to hair transplant surgery in general. , Bosley ... extremely effective way to eliminate the appearance of balding and ...
(Date:5/22/2013)... NJ (PRWEB) May 22, 2013 The health ... In some states, up to twenty-seven percent of all ... all bankruptcies of private citizens in the U.S. are related ... also affects prescription drugs, meaning that many patients cannot afford ... even get them filled at all. That's why MedicationDiscountCard.com ...
(Date:5/22/2013)... NJ (PRWEB) May 22, 2013 Officials ... today that its cicada services are now in full ... year that the cicada cycle emerges. , “The ... the year that they will emerge, so we’re now ... they are well protected during the invasion,” said R. ...
Breaking Medicine News(10 mins):Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 2Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 3Health News:Ethos Spa Skin And Laser Center Has Launched Their Customizable Gift Certificates 2Health News:TheBeautyPlace.com Divulges Two Innovative Hair Loss Concealers on the Market Today: Bosley Hair Thickening Fibers and Toppik Hair Building Fibers 2Health News:Lyrica Discount Cards Now Available From MedicationDiscountCard.com 2Health News:Alliance Commercial Pest Control, Inc. Now Offering Cicada Protection Services 2
... researcher has co-authored an international study that revealed a drug ... a rare lung disease in women. The life-threatening disease ... The clinical trial of the drug -- called sirolimus -- ... therapy for the lung disease, lymphangioleiomyomatosis, or LAM. LAM ...
... The wrist size of overweight or obese children and teens ... says a new study. Italian researchers measured the wrist ... They also used a painless nuclear imaging technique on about ... areas of the wrist more precisely. Blood tests were ...
... MONDAY, April 11 (HealthDay News) -- A drug commonly prescribed ... treating the mild stage of the disease, a new study ... effective in treating moderate to severe Alzheimer,s disease, "in mild ... works," said lead researcher Dr. Lon S. Schneider, a professor ...
... new discovery published online in The FASEB Journal ( ... likely to benefit from breast cancer drug therapies. If ... it would represent a significant advance for breast cancer ... some people. In addition, some drugs have side effects ...
... How your carotid artery moves can reveal your risk of ... study this vessel aspect in more detail thanks to a ... with suspected coronary artery disease, reveals a thesis from the ... arteries is associated with a risk of future heart disease, ...
... the journal Investigational New Drugs and conducted by researchers ... molecule inhibitors are showing promise in blocking STAT3, a ... osteosarcoma. These small molecule inhibitors one derived from ... as a new, non-toxic treatment for these deadly tumors. ...
Cached Medicine News:Health News:OHSU expert co-authors study finding treatment for rare lung disease 2Health News:Drug Memantine Ineffective for Mild Alzheimer's, Study Finds 2Health News:Drug Memantine Ineffective for Mild Alzheimer's, Study Finds 3Health News:Tiny antibody fragments raised in camels find drug targets in human breast cancer cells 2Health News:New potential atherosclerosis risk marker discovered 2Health News:New study finds compounds show promise in blocking STAT3 signaling as treatment for osteosarcoma 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: